f9352b-16ce-515b-b95b-6908dac4370d
at
ClaimsKG
http://data.gesis.org/claimskg/creative_work/89f9352b-16ce-515b-b95b-6908dac4370d
Property
Value
?:
citation
<
https://globenewswire.com/news-release/2016/07/05/853588/0/en/Insys-Therapeutics-Announces-FDA-Approval-of-Syndros.html?
>
<
https://herb.co/2017/11/25/dea-approved-synthetic-marijuana?
>
<
https://motherboard.vice.com/en_us/article/3dapvv/fda-approves-liquid-synthetic-weed-syndros?
>
<
https://news.vice.com/story/synthetic-thc-is-safer-than-actual-weed-according-to-the-dea?
>
<
https://snopes.com/fact-check/rating/mixture?
>
<
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/018651s029lbl.pdf?
>
<
https://www.dea.gov/druginfo/ds.shtml?
>
<
https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/ApprovalApplications/NewDrugApplicationNDA/default.htm?
>
<
https://www.federalregister.gov/documents/2017/03/23/2017-05809/schedules-of-controlled-substances-placement-of-fda-approved-products-of-oral-solutions-containing?
>
<
https://www.federalregister.gov/documents/2017/11/22/2017-25275/schedules-of-controlled-substances-placement-of-fda-approved-products-of-oral-solutions-containing?
>
<
https://www.sciencedirect.com/science/article/pii/S0376871614010333?
>
is
?:
itemReviewed
of
claimskg:
claim_review/7f5dbe62-d326-5264-b7cd-68b72ff7ce20
?:
keywords
claimskg:
keyword/2d6fbbd1-47a2-5d71-8e3c-1a383242729c
claimskg:
keyword/3e836009-23bd-5864-ac29-f6cd5ff0a564
claimskg:
keyword/67bae3f1-d50d-5129-8a5b-c239d37572c5
claimskg:
keyword/889d4a98-e92b-5c96-a277-ceece0ed855a
claimskg:
keyword/a7ac0b83-1f53-5016-b349-960f27fc7c14
claimskg:
keyword/bdb83f85-d5ae-5856-a7eb-fdfa40f9d3d7
claimskg:
keyword/c703f0a0-031f-5770-bc41-814f23131551
claimskg:
keyword/e81b648c-8b90-5ad4-9c1e-ff142b276231
?:
mentions
claimskg:
mention/3c1a8dfc-d23e-5097-8847-feb9bafc4ff2
claimskg:
mention/57c8843a-5e5a-50a9-9aea-a68fb9ce09dc
claimskg:
mention/9d0efe6b-d1c4-5bac-b65a-bc42b15991c6
claimskg:
mention/c6d74fde-d2ef-54e5-b905-72e4a0cf3ceb
?:
text
The DEA recently classified synthetic marijuana as a legally-obtainable Schedule II drug while continuing to list plant-based marijuana as a Schedule I drug with no currently accepted medical use.
(en)
rdf:
type
<
http://schema.org/CreativeWork
>